<DOC>
	<DOCNO>NCT02808611</DOCNO>
	<brief_summary>An extensive amount study indicate condition pain modulation ( CPM ) test paradigm use evaluate efficacy endogenous pain inhibition pathway healthy control pain patient . A number study indicate autonomic nervous system ( ANS ) respond painful stimulation parasympathetic activity withdrawal up-regulation sympathetic activity ( flight-or-fight mode ) , remain unknown whether response predict individual pain susceptibility CPM efficacy whether different pain modality evoke different physiological stress response , i.e . individual low pain tolerance exhibit vigorous ANS response subject controlled acute pain stimulus , high ANS responsiveness pain coincide alter psychophysical pain levels/CPM efficacy . This study aim investigate effect ANS responsiveness CPM paradigm investigate exogenous , pharmaceutically induced decrease sympathetic drive ANS yield decrease CPM efficacy .</brief_summary>
	<brief_title>Influence Propranolol Conditioned Pain Modulation</brief_title>
	<detailed_description />
	<mesh_term>Propranolol</mesh_term>
	<criteria>Healthy subject Drug addiction define use cannabis , opioids drug Previous history neurologic , musculoskeletal , mental illness chronic pain condition Lack ability cooperate Current use medication may affect trial , e.g. , analgesic , antiinflammatory drug Consumption alcohol , caffeine , nicotine painkiller morning termination study study day Recent history acute pain affect low limb Participation pain trial throughout study period Known diagnosis cardio vascular disease ( low blood pressure , heart condition ) Asthma Decreased function liver kidney Diabetes</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>